These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2695515)

  • 21. Serum autoantibodies in systemic lupus erythematosus and correlation with cutaneous features.
    Synkowski DR; Reichlin M; Provost TT
    J Rheumatol; 1982; 9(3):380-5. PubMed ID: 6981704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunology of systemic lupus erythematosus (literature review)].
    Belokrinitskii DV; Sura VV; Savel'ev AI
    Ter Arkh; 1970 Feb; 42(2):7-17. PubMed ID: 4192436
    [No Abstract]   [Full Text] [Related]  

  • 23. Systemic lupus erythematosus.
    Reichlin M
    Immunol Ser; 1991; 54():163-99. PubMed ID: 1954275
    [No Abstract]   [Full Text] [Related]  

  • 24. [Form of systemic lupus erythematosus (lupoid sclerosis) resembling multiple sclerosis].
    Stepień M; Cendrowski W
    Neurol Neurochir Pol; 1974; 8(4):607-9. PubMed ID: 4369567
    [No Abstract]   [Full Text] [Related]  

  • 25. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatoid and antinuclear factors.
    Holborow EJ
    J Belge Rhumatol Med Phys; 1967; 22(4):216. PubMed ID: 5306989
    [No Abstract]   [Full Text] [Related]  

  • 27. ANA-negative systemic lupus erythematosus.
    Ahmed AR; Workman S
    Clin Exp Dermatol; 1983 Jul; 8(4):369-77. PubMed ID: 6605221
    [No Abstract]   [Full Text] [Related]  

  • 28. [Routine immunofluorescence studies for demonstration of antinuclear factors].
    Hiemann D
    Z Gesamte Inn Med; 1969 May; 24(10):150-1. PubMed ID: 4185287
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunofluorescent investigations in the diagnosis of lupus erythematosus.
    Chorzelski T; Blaszczyk M; Jarzabek M
    Pol Med J; 1968; 7(2):479-85. PubMed ID: 4872573
    [No Abstract]   [Full Text] [Related]  

  • 30. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antinuclear factors. I. Clinical and immuno-pathologic significance].
    Peltier AP
    Presse Med (1893); 1970 Oct; 78(45):1969-73. PubMed ID: 4098224
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoantibodies in patients with psychiatric disease.
    Hazelton RA
    Aust N Z J Psychiatry; 1984 Jun; 18(2):191-2. PubMed ID: 6333236
    [No Abstract]   [Full Text] [Related]  

  • 33. Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus.
    Jearn LH; Kim DA; Kim TY
    J Rheumatol; 2009 Aug; 36(8):1833-4. PubMed ID: 19671822
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical significance of combined detection of 7 kinds of antinuclear antibodies with immunoblotting techniques].
    Qing Z
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):373-4. PubMed ID: 9868105
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serological study on antinuclear factors with special reference to its heterogeneity].
    Toyama T
    Arerugi; 1966 Mar; 15(3):158-64. PubMed ID: 4164274
    [No Abstract]   [Full Text] [Related]  

  • 36. Contemporary concepts for the clinical and laboratory evaluation of systemic lupus erythematosus and "lupus-like" syndromes.
    Nakamura RM; Bylund DJ
    J Clin Lab Anal; 1994; 8(6):347-59. PubMed ID: 7869173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies in patients with Lupus erythematosus: spectrum and frequencies.
    Wenzel J; Bauer R; Bieber T; Böhm I
    Dermatology; 2000; 201(3):282-3. PubMed ID: 11096213
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serum concentration of beta-2-microglobulin, immunologic parameters and kidney function in lupus erythematosus].
    Kolarz G; Scherak D; Fritzsche H; Weissel M
    Verh Dtsch Ges Rheumatol; 1978; 5():118-20. PubMed ID: 81571
    [No Abstract]   [Full Text] [Related]  

  • 39. Lupus erythematosus: laboratory testing and clinical subsets in the evaluation of patients.
    Synkowski DR; Mogavero HS; Provost TT
    Med Clin North Am; 1980 Sep; 64(5):921-40. PubMed ID: 6159506
    [No Abstract]   [Full Text] [Related]  

  • 40. ANA-negative SLE.
    Maddison PJ
    Clin Rheum Dis; 1982 Apr; 8(1):105-19. PubMed ID: 6749392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.